Top Menu

Archive | DTC-In-Perspective by Bob Ehrlich

FDA to Study Corrective DTC

FDA to Study Corrective DTC   “I applaud this to manage the corrective remedy.” -Bob Ehrlich Here is a topic that is clearly under-studied. If a drug company violates FDA promotional DTC regulations, is corrective advertising actually an appropriate remedy in correcting the original consumer misimpressions? While corrective advertising has been assumed to help […]

Continue Reading